• 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

LABD Share Price Performance

US$16.30
-88.50 (-84.45%)
US$16.30
-88.50 (-84.45%)
Price US$16.30

LABD Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Unattractive dividend payer with minimal risk.

1 Risk
0 Rewards

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X ETF Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$0

Other Expenses

US$0

Earnings

Last Reported Earnings
n/a
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About LABD

Founded
2015
Employees
n/a
CEO
n/a
WebsiteView website
www.direxion.com/product/daily-sp-biotech-bull-bear-3x-etfs

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X ETF is an exchange traded fund launched by Direxion Investments. It is managed by Rafferty Asset Management, LLC. It invests in public equity markets of the United States. It invests through derivatives and through other funds in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. It employs short strategy and uses derivatives such as futures, swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track -3x the daily performance of the S&P Biotechnology Select Industry Index. Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X ETF was formed on May 28, 2015 and is domiciled in the United States.

Recent LABD News & Updates

No updates

Recent updates

No updates